Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Disclosures: Chip Bowman: Nothing to Disclose, Elizabeth Verna: Nothing to Disclose 1762 OPTIMAL TREATMENT DURATION OF RESMETIROM FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A COST-EFFECTIVENESS ANALYSIS Phuc Le 1 William Herman 2 Srinivasan Dasarathy 1 Wen Ye 3 Victoria Criswell 1 Nicole Welch 1 Michael Rothberg 1 , 1 Cleveland Clinic, 2 University of Michigan at Ann Arbor Medical School, 3 University of Michigan at Ann Arbor School of Public Health Background: With recent approval from the US Food and Drug Administration, resmetirom is the first pharmacotherapy for metabolic dysfunction-associated steatohepatitis (MASH) and significant fibrosis (F2-F3)
Benefits of Semaglutide for Weight Loss Effective Appetite Control The most significant benefit is semaglutide is to control appetite, also reduce calorie intake, and weight loss
Metabolism: Clinical and Experimental
Prime/Select members can still get them if clinical criteria and prior authorization are met
